drugset / Trial / NCT02454751
The Use of Intranasal Fentanyl for the Treatment of Incident Dyspnea in Congestive Heart Failure: A Prospective Trial
NaSingle-groupOpen-labelTreatment
Summary
Study Objective The primary object of this study is to investigate the safety and effectiveness of fentanyl on the management of incident dyspnea. Study Design The study design will be a cross over study with a minimum of a one hour wash out period.
Timeline
- Start
- 2015-10
- Primary completion
- 2017-06-30
- Completion
- 2017-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fentanyl | Other / unclassified | 50 ug | Intranasal |